Related Experiment Videos
Pharmacokinetic studies with inhaled drugs
European Journal of Respiratory Diseases. Supplement
|January 1, 1982
Summary
The route of administration significantly impacts how the body processes asthma medications. Inhaled anti-asthmatic drugs achieve targeted action in airways due to pharmacokinetic and metabolic factors.
Area of Science:
- Pharmacology
- Drug Metabolism
- Respiratory Medicine
Background:
- Recent research has focused on the pharmacokinetics and metabolism of asthma treatments.
- The impact of drug administration routes on metabolism has been observed for various asthma medications.
Purpose of the Study:
- To review the influence of administration routes on the pharmacokinetics and metabolism of anti-asthmatic drugs.
- To highlight the role of these factors in achieving selective airway action.
Main Methods:
- Literature review of studies on anti-asthmatic drug pharmacokinetics and metabolism.
- Analysis of data concerning beta-adrenoceptor agonists, disodium cromoglycate, and glucocorticoids.
- Examination of the relationship between administration route, drug kinetics, and metabolic pathways.
Main Results:
- The route of administration affects the metabolism of drugs like isoprenaline, terbutaline, salbutamol, beclomethasone, and budesonide.
- Inhaled administration leads to selective action within the airways for many anti-asthmatic drugs.
- Pharmacokinetic and metabolic processes are crucial for the localized efficacy of inhaled asthma therapies.
Conclusions:
- Route of administration is a critical determinant of anti-asthmatic drug pharmacokinetics and metabolism.
- Understanding these factors is essential for optimizing drug delivery and therapeutic outcomes in asthma.
- Selective airway action of inhaled asthma medications is largely governed by pharmacokinetic and metabolic properties.